Anesthésie intraveineuse chez l’obèse : étude des posologies de propofol et de rémifentanil (étude multicentrique, prospective, ouverte comparant un groupe de patients obèses et un groupe de patients de poids normal) - Drone-Obésité

Hopital Foch0 个研究点目标入组 70 人开始时间: 2008年5月19日最近更新: 2012年3月19日

适应症

试验速览

暂无简介。

•Patients scheduled for a bariatric coelioscopic surgical procedure (obese patients) ou for a SUS-OBOLICAL coelioscopic surgical procedure (lean patients)
•Are the trial subjects under 18? no
•Number of subjects for this age range:
•F.1.2 Adults (18-64 years) yes
•F.1.2.1 Number of subjects for this age range
•F.1.3 Elderly (>=65 years) yes
•F.1.3.1 Number of subjects for this age range

•- age lower than 18 years,
•- pregnant woman,
•- presence of a central neurological disorder or a lesion cerebral, of a severe respiratory or hepatic insufficiency,
•- allergy to propofol, or to soja or to peanuts, or to sufentanil, or to remifentanil, or to morphine, or to a muscle myorelaxant, or to an excipient,
•- hypersensibility to sufentanil, or to remifentanil or to another derivate of fentanyl,
•- allergy to latex,
•- presence of a gastroesophageal reflux or of a hiatal hernia,
•- patients receiving a psychotropic treatment or a agonist-antagonist opiate,
•- presence of predictive signs of difficult mask ventilation of difficult intubation (else than obesity).

发起方